Medications prescribed to brain injury patients: A retrospective analysis

Optometry

Volumn 79, Issue 5, 2008, Pages 252-258

  Han, M H Esther ^a   Craig, Shoshana B ^a   Rutner, Daniella ^a   Kapoor, Neera ^a   Ciuffreda, Kenneth J ^a   Suchoff, Irwin B ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Acquired brain injury; Cerebrovascular accident; Medication side effects; Systemic medications; Traumatic brain injury; Vision symptoms

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN INJURY; CHILD; FEMALE; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; STROKE; VISUAL DISORDER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BRAIN INJURIES; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE; VISION DISORDERS;

EID: 43049120263     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2008.01.001     Document Type: Article

References (18)

1. Han M.E. Pharmacological agents commonly prescribed to patients with acquired brain injury. J Optom Vis Dev 34 (2003) 119-128
2. Jaanus S.D., Bartlett J.D., and Hiett J.A. Ocular effects of systemic drugs. In: Bartlett J.D., and Jaanus S.D. (Eds). Clinical ocular pharmacology (1995), Butterworth-Heinemann, Boston 957-1006
3. Olsen H. Opiod analgesics and antagonists. In: Dukes M.N.G., and Aronson J.K. (Eds). Meyler's side effects of drugs (2000), Elsevier, Amsterdam 198-230
4. Fraunfelder F.T., and Grove J.A. Drug-induced ocular side effects. Fourth ed. (1996), Williams & Wilkins, Baltimore
5. Borg S., and Ohman I. Antidepressants. In: Dukes M.N.G., and Aronson J.K. (Eds). Meyler's side effects of drugs (2000), Elsevier, Amsterdam 33-85
6. Helsing E. Vitamins. In: Dukes M.N.G., and Aronson J.K. (Eds). Meyler's side effects of drugs (2000), Elsevier, Amsterdam 1338-1363
7. Allen L.V. Nutritional Products. Handbook of nonprescription drugs (1993), American Pharmaceutical Association, Washington, DC 361-392
8. Phillips S.W., and Phillips J.D. Quick drug reference for the optometrist. Second ed. (1999), Anadem Publishing, Columbus
9. Jackowski M.M. Altered visual adaptation in patients with traumatic brain injury. In: Suchoff I.B., Ciuffreda K.J., and Kapoor N. (Eds). Visual and vestibular consequences of acquired brain injury (2001), Optometric Extension Program Foundation, Santa Ana 145-173
10. Du T., Ciuffreda K.J., and Kapoor N. Elevated dark adaptation thresholds in traumatic brain injury. Brain Injury 19; (2005) 1125-1138
11. Suchoff I.B., Ciuffreda K.J., and Kapoor N. Visual and vestibular consequences of acquired brain injury (2001), Optometric Extension Program Foundation, Santa Ana
12. Kapoor N., and Ciuffreda K.J. Vision disturbances following traumatic brain injury. Curr Treat Options Neurol 4 (2002) 271-280
13. Reinhard D.I., Whyte J., and Sandel M.E. Improved arousal and initiation following tricyclic antidepressant use in severe brain injury. Arch Phys Med Rehab 77 (1996) 80-83
14. Cope N. Psychopharmacologic aspects of traumatic brain injury. In: Horn L.J., and Zasler N.D. (Eds). Medical rehabilitation of traumatic brain injury (1996), Hanley and Belfus, Inc, Philadelphia 573-612
15. Teng C.J., Bhalerao S., Lee Z., et al. The use of bupropion in the treatment of restlessness after a traumatic brain injury. Brain Injury 15 (2001) 463-467
16. Goebel J.A. Management options for acute versus chronic vertigo. Otolaryngol Clin North Am 33 (2000) 483-493
17. Møller M.B. Selection criteria and treatment of patients with disabling positional vertigo. Sterotact Funct Neurosurg 68 (1997) 270-273
18. Fleminger S., Greenwood R.J., and Oliver D.L. Pharmacological management for agitation and aggression in people with acquired brain injury. (Cochrane Review). The Cochran Library (2003), Update Software, Oxford Issue 1